Review of solid-organ transplantation in HIV-infected patients.

PubWeight™: 1.37‹?› | Rank: Top 10%

🔗 View Article (PMID 12605104)

Published in Transplantation on February 27, 2003

Authors

Michelle E Roland1, Peter G Stock

Author Affiliations

1: Department of Medicine, University of California, San Francisco, California, USA. mroland@php.ucsf.edu

Articles citing this

HIV-positive-to-HIV-positive kidney transplantation--results at 3 to 5 years. N Engl J Med (2015) 4.81

Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis (2014) 2.16

HIV and kidney disease in sub-Saharan Africa. Nat Rev Nephrol (2009) 1.40

Canadian Society of Transplantation: consensus guidelines on eligibility for kidney transplantation. CMAJ (2005) 1.26

Disease recurrence in paediatric renal transplantation. Pediatr Nephrol (2009) 1.10

Virologic and clinical outcomes of hepatitis B virus infection in HIV-HBV coinfected transplant recipients. Am J Transplant (2010) 1.05

Kidney disease in children and adolescents with perinatal HIV-1 infection. J Int AIDS Soc (2013) 0.97

Renal transplantation in patients with HIV. Nat Rev Nephrol (2009) 0.92

Beyond the NIH Multicenter HIV Transplant Trial Experience: Outcomes of HIV+ Liver Transplant Recipients Compared to HCV+ or HIV+/HCV+ Coinfected Recipients in the United States. Clin Infect Dis (2015) 0.90

Treatment-dependent loss of polyfunctional CD8+ T-cell responses in HIV-infected kidney transplant recipients is associated with herpesvirus reactivation. Am J Transplant (2009) 0.88

Surgical complications in 275 HIV-infected liver and/or kidney transplantation recipients. Surgery (2012) 0.83

Renal transplantation in a HIV positive patient. Indian J Nephrol (2009) 0.81

The physical and psychological effects of HIV infection and its treatment on perinatally HIV-infected children. J Int AIDS Soc (2015) 0.79

Renal transplantation in HIV patients: A series of four cases. Indian J Nephrol (2012) 0.78

Ethical and scientific issues surrounding solid organ transplantation in HIV-positive patients: Absence of evidence is not evidence of absence. Can J Infect Dis Med Microbiol (2006) 0.78

Liver transplantation(). J Ultrasound (2007) 0.77

HIV-positive-to-HIV-positive kidney transplantation. N Engl J Med (2015) 0.77

Kidney donation: Clinical practice and ethical dilemmas. Indian J Nephrol (2016) 0.75

Successful Orthotopic Heart Transplantation and Immunosuppressive Management in 2 Human Immunodeficiency Virus-Seropositive Patients. Tex Heart Inst J (2016) 0.75

Solid organ transplantation and HIV: A changing paradigm. Can J Infect Dis Med Microbiol (2008) 0.75

Getting to 90-90-90 in paediatric HIV: What is needed? J Int AIDS Soc (2015) 0.75

Articles by these authors

Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection. Liver Transpl (2012) 4.65

Improvement in outcomes of clinical islet transplantation: 1999-2010. Diabetes Care (2012) 3.20

Management of the Potential Organ Donor in the ICU: Society of Critical Care Medicine/American College of Chest Physicians/Association of Organ Procurement Organizations Consensus Statement. Crit Care Med (2015) 2.42

HLA-DR matching in organ allocation: balance between waiting time and rejection in pediatric kidney transplantation. Arch Surg (2011) 2.09

Predictors associated with terminal renal function in deceased organ donors in the intensive care unit. Anesthesiology (2009) 1.60

Outcome of patients with hepatitis B virus and human immunodeficiency virus infections referred for liver transplantation. Liver Transpl (2006) 1.59

The rationale for the new deceased donor pancreas allocation schema. Transplantation (2007) 1.58

Current status of kidney and pancreas transplantation in the United States, 1994-2003. Am J Transplant (2005) 1.37

Islet transplantation in type 1 diabetic patients using calcineurin inhibitor-free immunosuppressive protocols based on T-cell adhesion or costimulation blockade. Transplantation (2010) 1.23

Delayed hepatocellular carcinoma model for end-stage liver disease exception score improves disparity in access to liver transplant in the United States. Hepatology (2015) 1.20

Successful clinical islet isolation using a GMP-manufactured collagenase and neutral protease. Transplantation (2009) 1.11

Cyclosporine pharmacokinetics and dosing modifications in human immunodeficiency virus-infected liver and kidney transplant recipients. Transplantation (2005) 1.10

End stage polycystic kidney disease: indications and timing of native nephrectomy relative to kidney transplantation. J Urol (2005) 1.00

Determinants of transplant surgeons' willingness to provide organs to patients infected with HBV, HCV or HIV. Am J Transplant (2005) 0.95

Liver and kidney transplantation in HIV-infected patients. AIDS Rev (2009) 0.95

BKV in simultaneous pancreas-kidney transplant recipients: a leading cause of renal graft loss in first 2 years post-transplant. Am J Transplant (2005) 0.93

Solid organ transplantation: referral, management, and outcomes in HIV-infected patients. AIDS Read (2006) 0.93

Renal transplantation in patients with HIV. Nat Rev Nephrol (2009) 0.92

Review of transplantation in HIV patients during the HAART era. Clin Transpl (2004) 0.91

Liver transplantation in HIV-infected recipients. Semin Liver Dis (2006) 0.90

Solid organ transplantation is a reality for patients with HIV infection. Curr HIV/AIDS Rep (2006) 0.89

Best single time point correlations with AUC for cyclosporine and tacrolimus in HIV-infected kidney and liver transplant recipients. Transplantation (2014) 0.87

Clinical Trials for Immunosuppression in Transplantation; The Case for Reform and Change in Direction. Transplantation (2017) 0.87

Key clinical, ethical, and policy issues in the evaluation of the safety and effectiveness of solid organ transplantation in HIV-infected patients. Arch Intern Med (2003) 0.87

Management of lymphoceles after renal transplantation: laparoscopic versus open drainage. J Urol (2003) 0.84

Rapid deterioration of HIV co-infected patients waiting for liver transplantation is not predicted by MELD. Liver Transpl (2005) 0.84

Surgical complications in 275 HIV-infected liver and/or kidney transplantation recipients. Surgery (2012) 0.83

Phenotypic analysis of NS5A variant from liver transplant patient with increased cyclosporine susceptibility. Virology (2013) 0.83

Survival in HIV-positive transplant recipients compared with transplant candidates and with HIV-negative controls. AIDS (2016) 0.82

Viable strategies to facilitate liver transplantation for human immunodeficiency virus coinfection. Liver Transpl (2009) 0.82

Successful long-term outcomes using pediatric en bloc kidneys for transplantation. Am J Transplant (2002) 0.80

Liver transplantation in HIV patients. Semin Liver Dis (2012) 0.79

Malignancy in the HIV-infected patients undergoing liver and kidney transplantation. Curr Opin Oncol (2012) 0.78

Targeted gene therapy with CD40Ig to induce long-term acceptance of liver allografts. Surgery (2002) 0.78

Clinical islet transplantation at the University of California, San Francisco. Clin Transpl (2010) 0.78

Ethical issues in split versus whole liver transplantation. Am J Transplant (2004) 0.77

Current outcomes in islet versus solid organ pancreas transplant for β-cell replacement in type 1 diabetes. Curr Opin Organ Transplant (2016) 0.76

[Comprehensive guidelines translate research findings into clinical policy for HIV-infected transplant candidates and recipients]. Enferm Infecc Microbiol Clin (2005) 0.75

Canadian Laws Are On Target - but is the transplant community? Transplantation (2017) 0.75

ß cell replacement therapy: the next 10 years. Transplantation (2017) 0.75

The Effect of HLA-DR Matching on Pediatric Kidney Transplantation-Reply. Arch Surg (2012) 0.75

Long-term survival and renal transplantation in a monozygotic twin with cloacal dysgenesis sequence. J Pediatr Surg (2009) 0.75

Erratum. National Institutes of Health-Sponsored Clinical Islet Transplantation Consortium Phase 3 Trial: Manufacture of a Complex Cellular Product at Eight Processing Facilities. Diabetes 2016;65:3418-3428. Diabetes (2017) 0.75